Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,600
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
for
Colorectal Adenocarcinoma
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT06225011
Phase 1, Recruiting
Ability of Modulated Imaging and Laser Speckle Imaging to Determine Burn Wound Severity and Healing Potential
for
Skin Burn Multiple
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 0+
Code: NCT01166893
Recruiting
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE)
for
Lupus Erythematosus, Systemic
Location: Los Angeles CA, Charlotte NC, Manhasset NY
Sponsor: Ampel BioSolutions, LLC
Sex: All
Age: 18+
Code: NCT05845593
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Los Angeles CA, Santa Clara CA, Oakland CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Relapsed and/or Refractory Multiple Myeloma
Location: Duarte CA, Stanford CA, San Francisco CA, Denver CO,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06153251
Phase 1, Recruiting
Evaluating BMD in Participants ≥50 Years Old Switching From EVG/COBI/FTC/TAF or EVG/COBI/FTC/TDF to ABC/DTG/3TC
for
Infection, Human Immunodeficiency Virus
Location: Los Angeles CA
Sponsor: Mills Clinical Research
Sex: All
Age: 50+
Code: NCT03275701
Recruiting
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer